Concord Historical Financial Ratios
| CCM Stock | USD 4.45 0.25 5.95% |
Concord Medical is presently reporting on over 123 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.12, Days Sales Outstanding of 47.42 or Book Value Per Share of 252 will help investors to properly organize and evaluate Concord Medical Services financial condition quickly.
Concord |
About Concord Financial Ratios Analysis
Concord Medical ServicesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Concord Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Concord financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Concord Medical history.
Concord Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Concord Medical Services stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Concord Medical sales, a figure that is much harder to manipulate than other Concord Medical Services multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Concord Medical Services dividend as a percentage of Concord Medical stock price. Concord Medical Services dividend yield is a measure of Concord Medical stock productivity, which can be interpreted as interest rate earned on an Concord Medical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Concord Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Concord Medical's Inventory Turnover is very stable compared to the past year. As of the 22nd of November 2024, Days Payables Outstanding is likely to grow to 80.67, while Dividend Yield is likely to drop 0.12.
| 2023 | 2024 (projected) | Dividend Yield | 0.19 | 0.12 | Price To Sales Ratio | 0.66 | 0.63 |
Concord Medical fundamentals Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 4.06 | 3.5 | 1.14 | 1.05 | 0.66 | 0.63 | |
| Ptb Ratio | (6.57) | (1.18) | (0.41) | (0.27) | (0.17) | (0.16) | |
| Days Sales Outstanding | 200.51 | 167.63 | 98.16 | 100.72 | 49.92 | 47.42 | |
| Book Value Per Share | 435.18 | 549.58 | 628.07 | 461.41 | 399.91 | 251.57 | |
| Free Cash Flow Yield | (0.76) | (1.11) | (0.95) | (2.05) | (1.22) | (1.06) | |
| Operating Cash Flow Per Share | (45.0) | (52.6) | (82.25) | (49.6) | (63.29) | (60.12) | |
| Stock Based Compensation To Revenue | 0.1 | 0.0925 | 0.0302 | (0.0125) | (0.0113) | (0.0107) | |
| Capex To Depreciation | 12.45 | 6.39 | 7.5 | 2.9 | 0.93 | 0.89 | |
| Pb Ratio | (6.57) | (1.18) | (0.41) | (0.27) | (0.17) | (0.16) | |
| Ev To Sales | 13.03 | 12.56 | 6.45 | 7.57 | 6.69 | 6.35 | |
| Free Cash Flow Per Share | (206.59) | (170.01) | (260.87) | (137.69) | (90.74) | (95.27) | |
| Roic | (0.34) | (0.19) | (0.54) | (0.42) | (0.47) | (0.45) | |
| Inventory Turnover | 49.34 | 9.71 | 14.25 | 7.36 | 15.22 | 26.02 | |
| Net Income Per Share | (127.27) | (153.35) | (187.85) | (112.09) | (68.14) | (71.54) | |
| Days Of Inventory On Hand | 7.4 | 37.57 | 25.62 | 49.58 | 23.98 | 22.79 | |
| Payables Turnover | 25.88 | 11.27 | 5.29 | 4.26 | 4.75 | 4.51 | |
| Sales General And Administrative To Revenue | 1.53 | 1.59 | 1.32 | 0.66 | 0.61 | 0.44 | |
| Capex To Revenue | 3.54 | 2.3 | 1.61 | 0.82 | 0.22 | 0.21 | |
| Cash Per Share | 17.12 | 76.52 | 36.03 | 36.23 | 13.31 | 12.64 | |
| Pocfratio | (4.13) | (3.4) | (1.54) | (2.28) | (1.29) | (1.23) | |
| Interest Coverage | (15.24) | (3.78) | (6.21) | (4.36) | (2.79) | (2.65) | |
| Capex To Operating Cash Flow | (3.59) | (2.23) | (2.17) | (1.78) | (0.43) | (0.46) | |
| Pfcf Ratio | (1.32) | (0.9) | (1.05) | (0.49) | (0.82) | (0.85) | |
| Days Payables Outstanding | 14.1 | 32.4 | 68.96 | 85.77 | 76.82 | 80.67 | |
| Income Quality | 0.55 | 0.57 | 0.69 | 0.28 | 0.52 | 0.49 | |
| Roe | (0.82) | 4.5 | 1.01 | 0.6 | 0.26 | 0.27 | |
| Ev To Operating Cash Flow | (13.23) | (12.19) | (8.71) | (16.5) | (13.0) | (12.35) | |
| Pe Ratio | (1.46) | (1.17) | (0.68) | (1.01) | (1.2) | (1.14) | |
| Return On Tangible Assets | (0.1) | (0.16) | (0.15) | (0.18) | (0.0577) | (0.0606) | |
| Ev To Free Cash Flow | (2.88) | (3.77) | (2.75) | (5.94) | (9.07) | (8.61) | |
| Earnings Yield | (0.69) | (0.86) | (1.48) | (0.99) | (0.83) | (0.79) | |
| Net Debt To E B I T D A | (5.99) | (7.89) | (7.33) | (5.25) | (10.32) | (9.8) | |
| Current Ratio | 0.45 | 1.32 | 0.73 | 0.68 | 0.32 | 0.3 | |
| Tangible Book Value Per Share | 264.05 | 380.99 | 248.85 | 155.24 | 194.18 | 151.36 | |
| Receivables Turnover | 1.82 | 2.18 | 3.72 | 3.62 | 7.31 | 7.68 | |
| Graham Number | 284.57 | 723.62 | 1.2K | 1.0K | 862.96 | 906.1 | |
| Shareholders Equity Per Share | (28.28) | (151.76) | (313.64) | (426.69) | (485.74) | (461.45) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.97) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.